Analyst Recommendations

Wedbush analyst issues NEUTRAL recommendation for CRI on February 23, 2024 12:00PM ET. The previous analyst recommendation was Neutral.CRI was trading at $82.28 at issue of the analyst...

February 23, 2024   CRI -1.82%

Wedbush analyst issues EQUAL-WEIGHT recommendation for ZD on February 23, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight.ZD was trading at $69.34 at issue of the analyst...

February 23, 2024   ZD -0.26%

Barclays analyst issues EQUAL-WEIGHT recommendation for FNF on February 23, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight.FNF was trading at $50.245 at issue of the analyst...

February 23, 2024   FNF 1.25%

Susquehanna analyst issues POSITIVE recommendation for TRN on February 23, 2024 12:00PM ET. The previous analyst recommendation was Positive.TRN was trading at $24.64 at issue of the analyst...

February 23, 2024   TRN -0.78%

Citigroup analyst issues BUY recommendation for FOXA on February 23, 2024 08:22AM ET. FOXA was trading at $29.85 at issue of the analyst recommendation.The overall analyst consensus :...

February 23, 2024   FOXA 0.09%

Wedbush analyst issues MARKET PERFORM recommendation for BLDR on February 23, 2024 09:00AM ET. The previous analyst recommendation was Market Perform.BLDR was trading at $188.37 at issue of...

February 23, 2024   BLDR 0.10%

Needham analyst issues BUY recommendation for BELFB on February 23, 2024 08:22AM ET. The previous analyst recommendation was Buy.BELFB was trading at $50.02 at issue of the analyst...

February 23, 2024   BELFB 0.54%

Piper Sandler analyst issues OVERWEIGHT recommendation for INTU on February 23, 2024 08:22AM ET. The previous analyst recommendation was Overweight.INTU was trading at $657.92 at issue of the...

February 23, 2024   INTU 0.64%

RBC Capital analyst issues HOLD recommendation for MRNA on February 23, 2024 10:00AM ET. The previous analyst recommendation was Hold.MRNA was trading at $99.46 at issue of the...

February 23, 2024   MRNA 1.52%

Oppenheimer analyst issues UNDERPERFORM recommendation for BLDR on February 23, 2024 09:00AM ET. The previous analyst recommendation was Underperform.BLDR was trading at $188.37 at issue of the analyst...

February 23, 2024   BLDR 0.10%